1. Home
  2. HLMN vs BLTE Comparison

HLMN vs BLTE Comparison

Compare HLMN & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLMN
  • BLTE
  • Stock Information
  • Founded
  • HLMN 1964
  • BLTE 2018
  • Country
  • HLMN United States
  • BLTE United States
  • Employees
  • HLMN N/A
  • BLTE N/A
  • Industry
  • HLMN Industrial Machinery/Components
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • HLMN Consumer Discretionary
  • BLTE Health Care
  • Exchange
  • HLMN Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • HLMN 2.2B
  • BLTE 2.1B
  • IPO Year
  • HLMN N/A
  • BLTE 2022
  • Fundamental
  • Price
  • HLMN $10.76
  • BLTE $82.81
  • Analyst Decision
  • HLMN Strong Buy
  • BLTE Strong Buy
  • Analyst Count
  • HLMN 6
  • BLTE 4
  • Target Price
  • HLMN $12.92
  • BLTE $89.00
  • AVG Volume (30 Days)
  • HLMN 815.0K
  • BLTE 110.7K
  • Earning Date
  • HLMN 11-05-2024
  • BLTE 11-12-2024
  • Dividend Yield
  • HLMN N/A
  • BLTE N/A
  • EPS Growth
  • HLMN N/A
  • BLTE N/A
  • EPS
  • HLMN 0.04
  • BLTE N/A
  • Revenue
  • HLMN $1,470,841,000.00
  • BLTE N/A
  • Revenue This Year
  • HLMN $1.66
  • BLTE N/A
  • Revenue Next Year
  • HLMN $5.26
  • BLTE N/A
  • P/E Ratio
  • HLMN $276.66
  • BLTE N/A
  • Revenue Growth
  • HLMN N/A
  • BLTE N/A
  • 52 Week Low
  • HLMN $7.05
  • BLTE $31.01
  • 52 Week High
  • HLMN $12.08
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • HLMN 49.58
  • BLTE 73.39
  • Support Level
  • HLMN $11.00
  • BLTE $77.62
  • Resistance Level
  • HLMN $11.38
  • BLTE $86.53
  • Average True Range (ATR)
  • HLMN 0.36
  • BLTE 5.84
  • MACD
  • HLMN -0.03
  • BLTE 0.69
  • Stochastic Oscillator
  • HLMN 29.03
  • BLTE 88.01

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the group are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the US, Canada and Mexico.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: